Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Medford, OR
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Medford, OR
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Oregon City, OR
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Oregon City, OR
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis
mi
from
Portland, OR
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Langhorne, PA
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Langhorne, PA
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis
mi
from
Pittsburgh, PA
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Pottstown, PA
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Pottstown, PA
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Tipton, PA
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Tipton, PA
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
East Providence, RI
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
East Providence, RI
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Fort Mill, SC
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Fort Mill, SC
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Rock Hll, SC
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Rock Hll, SC
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Denton, TX
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Denton, TX
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis
mi
from
San Antonio, TX
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Midvale, UT
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Midvale, UT
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
South Burlington, VT
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
South Burlington, VT
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Richmond, VA
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Richmond, VA
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  8/20/2013
Novartis Investigative Site
mi
from
Tacoma, WA
NVA237 BID Versus Placebo Twelve-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 8/20/2013
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
Matrix Institute on Addictions
mi
from
Los Angeles, CA
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
VA San Diego Healthcare System
mi
from
San Diego, CA
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
VA Medical Center - Denver, CO
mi
from
Denver, CO
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
VA Medical Center - Denver, CO
mi
from
Denver, CO
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
Mountain Manor Treatment Center at Baltimore
mi
from
Baltimore, MD
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
Mountain Manor Treatment Center at Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
Pacific Institute for Research and Evaluation
mi
from
Albuquerque, NM
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
Pacific Institute for Research and Evaluation
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
Columbia University Medical Center
mi
from
New York, NY
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
Cincinnati Addiction Research Center
mi
from
Cincinnati, OH
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
Cincinnati Addiction Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
University of Pennsylvania, Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated:  8/21/2013
George E. Wahlen VA Medical Center
mi
from
Salt Lake City, UT
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
Status: Enrolling
Updated: 8/21/2013
George E. Wahlen VA Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Lewes, DE
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Lewes, DE
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Atlanta, GA
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Ashland, KY
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Ashland, KY
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Baltimore, MD
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Duluth, MN
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Duluth, MN
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Albuquerque, NM
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Rochester, NY
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Akron, OH
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Norman, OK
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Norman, OK
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Cranston, RI
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Cranston, RI
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Anderson, SC
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Bristol, TN
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Bristol, TN
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
Houston, TX
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated:  8/30/2013
Pfizer Investigational Site
mi
from
West Jordan, UT
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Status: Enrolling
Updated: 8/30/2013
Pfizer Investigational Site
mi
from
West Jordan, UT
Click here to add this to my saved trials